Almost every prescription bottle in a South Florida medicine cabinet carries a warning about possible side effects. Some of those effects are mild and expected. Some are serious. A small number reflects something the manufacturer should have caught, warned about, or never have allowed to reach a patient in the first place.
The line between an unfortunate but legally tolerated side effect and an actionable injury is one of the most misunderstood points in pharmaceutical law. Patients who have been seriously harmed often assume nothing can be done because the drug was FDA-approved or because side effects were listed on the label. Both assumptions are wrong as often as they are right. At Weinstein & Cohen, we want clients and referring counsel across Miami-Dade, Broward, Palm Beach, and Collier County to understand exactly when a pharmaceutical company can be held responsible for the harm caused by one of its products.
The Baseline: Some Risk Is Legally Acceptable
Before getting to the grounds for liability, it helps to acknowledge what the law does not treat as a wrong. Every drug carries some risk profile. A cholesterol-lowering medication may cause muscle aches in a small percentage of patients. An antibiotic may produce gastrointestinal distress. Even widely used over-the-counter products list real adverse effects on their packaging. Side effects of that kind, accurately disclosed and proportionate to the drug’s intended benefit, are part of the bargain regulators and the legal system have struck with pharmaceutical innovation.
The cases we handle are not those. The cases we handle involve serious or fatal complications that should not have happened, that the manufacturer either knew about or should have known about, and that were not adequately disclosed or, in some instances, never should have been on the market at all.
Design Defects: The Drug Itself Was Unsafe
A drug suffers from a design defect when it is unreasonably dangerous even when manufactured exactly as intended and taken at the recommended dose. The formulation itself is the problem. Clinical trials are supposed to surface these issues before a drug reaches pharmacy shelves, but they do not always do so, and history is full of examples of drug makers pushing products to market faster than the science justified.
A claim built on a design defect does not require proving that the manufacturer was careless. It requires proving that the product was defective and that the defect caused the patient’s harm. This is one of the strongest theories in pharmaceutical litigation precisely because the legal focus is on the product rather than the company’s state of mind.
Manufacturing Defects: Something Went Wrong on the Production Line
A manufacturing defect exists when the drug, as designed, would have been reasonably safe, but a specific batch or production run deviated from specifications. Contamination, improper formulation, sterilization failures, and packaging problems that allow a product to spoil or interact with the environment all fall into this category. Generic manufacturers, particularly those operating overseas with little oversight, have been responsible for more than a few of the cases that appear in U.S. litigation.
As with design defects, a manufacturing defect claim does not require a separate showing of negligence. The defective product itself is wrong, and the patient’s burden is to connect that defect to the injury.
Failure to Warn: The Risk Was Real, and the Label Did Not Say So
A pharmaceutical company is required to disclose, on its labels and in its prescribing information, the known risks of its product, as well as the risks it should have known about based on the testing required by law and good science. When a manufacturer hides a risk, downplays a risk, or fails to update a label as new safety data emerges, that is the territory of failure to warn.
This is often the most fact-intensive of the three product theories. It involves digging through the company’s internal documents, comparing what the manufacturer knew and when it knew it against what made it onto the label, and demonstrating that an adequate warning would have changed the prescribing physician’s decision or the patient’s choice. Done well, it is also one of the most powerful theories because the evidence often shows that the company recognized the warning signs long before the public did.
Negligence and, Sometimes, Worse
Patients can also pursue traditional negligence claims when the facts support them. Common examples include inadequate testing, statistically underpowered clinical trials, misinterpretation of trial data, lapses in quality control, and inadequate sterilization procedures. The more troubling category, and the one that drives some of the largest verdicts in pharmaceutical litigation, involves intentional wrongdoing. When a manufacturer knew of a serious risk, calculated that the cost of litigation would be lower than the cost of a recall or a label change, and let patients keep getting hurt, that is not just negligence. It is conduct that can support punitive damages designed to punish the company and deter others.
How Florida Law Affects Pharmaceutical Cases
For South Florida claimants, a few state-specific points matter. Florida’s statute of limitations for product liability claims, including pharmaceutical claims, is generally four years, with a 12-year statute of repose that applies in many circumstances. Florida also follows a modified comparative negligence framework following the 2023 tort reform, but it applies differently to product cases than to standard negligence cases, which is another reason these matters need to be evaluated by counsel familiar with both bodies of law.
Many pharmaceutical cases are also handled as part of multidistrict litigation or coordinated proceedings rather than individual lawsuits. For patients across Miami-Dade, Broward, Palm Beach, and Collier Counties, that often means joining an existing mass tort with substantial discovery already underway, which can meaningfully alter the timeline and strategy.
When to Talk to a Lawyer
The honest test is not whether a patient has a legal claim. It is whether the harm was serious enough, the connection to the drug clear enough, and the time still available short enough to merit a real investigation. Any patient or family in South Florida dealing with a serious complication from a prescription or over-the-counter medication should be evaluated by counsel who handles both individual product liability and mass tort work. The conversation costs nothing. The deadline does not wait.
Final Thoughts
Pharmaceutical companies are not insurers of every patient’s outcome, but they are accountable when their products cause serious harm, and the cause can be traced to a defect, an inadequate warning, or corporate conduct that puts profit ahead of safety. At Weinstein & Cohen, we combine decades of trial experience with a personal, boutique approach to help patients and families understand whether they have a claim, determine whether participation in a mass tort is the right path, and pursue the manufacturers responsible for the harm. If you or a loved one has experienced a serious or fatal complication from a medication, please contact us for a free consultation. Visit our website at www.fairnessforall.com or call 305-374-1011 today. Let us help you understand your rights, evaluate your claim, and fight for the compensation and justice you deserve.
